Redmile Group, LLC bought $10.2M of Attovia Therapeutics (ATTO)

Executed Aug 6, disclosed Aug 8, 1 day later.

Value, as filed

$10.2M

600,000 sh across 2 lots

Executed

Aug 6

the trade date, as filed

Disclosed

Aug 8

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+27.1%

+9.8% from execution

Over the 21 trading sessions from the disclosed entry session (Aug 7), the stock returned +27.1% (delay-adjusted); from the execution session (Aug 6), +9.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

RL Redmile Group, LLC 10% owner profile →

Redmile Group, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in Attovia Therapeutics, Inc. Common Stock (ATTO). Across 1 priced purchase filing, the average 21-session return was +9.8% from execution and +27.1% from disclosure (delay-adjusted; derived). The largest single filing was $10.2M of ATTO (600,000 sh across 2 lots, as filed), executed Aug 6.

The name

ATTO

Attovia Therapeutics, Inc. Common Stock ATTO · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→